Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson's disease-like symptoms in Wistar rats
- PMID: 40379880
- DOI: 10.1007/s10534-025-00693-7
Ferrous sulfate and lipopolysaccharide co-exposure induce neuroinflammation, neurobehavioral motor deficits, neurodegenerative and histopathological biomarkers relevant to Parkinson's disease-like symptoms in Wistar rats
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra region of the brain. Although iron is one of the essential micronutrients in the brain, its excess exposure and accumulation in the brain substantia nigra and striatum regions may induce critical pathological changes relevant to PD. This study has evaluated neurobehavioral, biochemical, and structural alterations resembling PD-like symptoms induced through a 4-week co-exposure of ferrous sulfate (FeSO4) with lipopolysaccharide (LPS) in Wistar rats. Our results revealed motor deficits, oxidative stress, neuroinflammation, iron dysregulation, protein aggregation, ferroptosis, and apoptotic cell death. Notably, we observed decreased tyrosine hydroxylase levels and increased α-synuclein accumulation, consistent with PD pathology. The immunohistopathological assessments showed astrocyte activation and iron deposition, supporting their roles in neuroinflammation and oxidative stress. Furthermore, we identified alterations in apoptosis and ferroptosis markers, suggesting dose-related involvement of FeSO4 in neuronal death in the rat brain. These findings have highlighted the multifaceted mechanisms during the co-exposure of FeSO4 and LPS-induced neurodegeneration and neuroinflammation relevant to PD. This study emphasizes that therapeutic targeting of these pathological mechanisms may offer a promising therapeutic intervention in PD.
Keywords: Ferroptosis; Iron; Lipopolysaccharide; Neuroinflammation; Parkinson’s disease.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no conflict of interest. Ethical approval: All the procedures and protocols were approved by the Institutional Animal Ethics Committee (IAEC) of NIPER-Raebareli, Lucknow, India (Protocol Number NIPER/RBL/IAEC/135/June 2023) and used in the experiment as per the provisions laid down by the Committee for Control and Supervision of Experiments on Animals (CCSEA), India. Informed consent: Not applicable.
Similar articles
-
Betulinic acid protects against lipopolysaccharide and ferrous sulfate-induced oxidative stress, ferroptosis, apoptosis, and neuroinflammation signaling relevant to Parkinson's Disease.Free Radic Biol Med. 2025 Jun;233:340-354. doi: 10.1016/j.freeradbiomed.2025.04.013. Epub 2025 Apr 7. Free Radic Biol Med. 2025. PMID: 40203997
-
GIT 27 modulates TLR4/Src/NOX2 signaling pathway: A potential therapeutic strategy to decrease neuroinflammation, oxidative stress and neuronal cell death in Parkinson's disease.Free Radic Biol Med. 2025 Oct;238:64-77. doi: 10.1016/j.freeradbiomed.2025.06.035. Epub 2025 Jun 20. Free Radic Biol Med. 2025. PMID: 40545151
-
Neuroprotective effects of a cannabidiol nanoemulsion in a rotenone-induced rat model of Parkinson's disease: Insights into the gut-brain axis.Eur J Pharmacol. 2025 Sep 5;1002:177748. doi: 10.1016/j.ejphar.2025.177748. Epub 2025 May 25. Eur J Pharmacol. 2025. PMID: 40425082
-
Berberine's paradox in Neurodegeneration: Therapeutic promise and safety challenges in Parkinson's disease.Neuropharmacology. 2025 Nov 1;278:110555. doi: 10.1016/j.neuropharm.2025.110555. Epub 2025 Jun 6. Neuropharmacology. 2025. PMID: 40482960 Review.
-
Combating Parkinson's disease with plant-derived polyphenols: Targeting oxidative stress and neuroinflammation.Neurochem Int. 2024 Sep;178:105798. doi: 10.1016/j.neuint.2024.105798. Epub 2024 Jun 29. Neurochem Int. 2024. PMID: 38950626 Review.
References
-
- Angelova PR, Choi ML, Berezhnov AV, Horrocks MH, Hughes CD, De S, Rodrigues M, Yapom R, Little D, Dolt KS, Kunath T, Devine MJ, Gissen P, Shchepinov MS, Sylantyev S, Pavlov EV, Klenerman D, Abramov AY, Gandhi S (2020) Correction: alpha synuclein aggregation drives ferroptosis: an interplay of iron, calcium and lipid peroxidation. Cell Death Differ 27:2747. https://doi.org/10.1038/s41418-020-0552-x - DOI
-
- Antipova V, Holzmann C, Hawlitschka A, Witt M, Wree A (2021) Antidepressant-like properties of intrastriatal botulinum neurotoxin-A injection in a unilateral 6-OHDA rat model of Parkinson’s disease. Toxins. https://doi.org/10.3390/toxins13070505 - DOI
-
- Baral B, Chauhan C, Mishra T, Kaundal RK (2025) Neuroprotective effects of Saxagliptin in traumatic brain injury: ameliorating oxidative stress, neuroinflammation, and apoptosis. Metab Brain Dis 40:175. https://doi.org/10.1007/s11011-025-01584-z - DOI
-
- Beier EE, Neal M, Alam G, Edler M, Wu LJ, Richardson JR (2017) Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide. Neurobiol Dis 108:115–127. https://doi.org/10.1016/j.nbd.2017.08.009 - DOI
-
- Boyd RJ, Avramopoulos D, Jantzie LL, McCallion AS (2022) Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. J Neuroinflamm 19:223. https://doi.org/10.1186/s12974-022-02584-x - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical